Skip to main content

Differentiating Hemodynamic Compromise by the OEF Response to Acetazolamide in Occlusive Vascular Disease

  • Conference paper

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 566))

Abstract

Identification of increased stroke risk in a population of symptomatic patients with occlusive vascular disease (OVD) is presently accomplished by measurement of oxygen extraction fraction (OEF) or cerebrovascular reserve (CVR). However, many regions identified by compromised CVR are not identified by OEF. Our aim was to determine whether the response of OEF to acetazolamide, namely, oxygen extraction fraction response (OEFR) would identify those hemispheres in hemodynamic compromise with normal OEF. Nine patients symptomatic with transient ischemic attacks and strokes, and with occlusive vascular disease were studied. Anatomical MRI scans and T2-weighted images were used to identify and grade subcortical white matter infarcts. PET cerebral blood flow (CBF) and OEF were measured after acetazolamide. The relationship between CVR and oxygen extraction fraction response (OEFR) showed that positive OEFR occurred after acetazolamide despite normal baseline OEF values. The two hemispheres with positive OEFR were also associated with severe (> 3 cm) subcortical white matter infarcts. We found that the OEFR was highly correlated with CVR and identified hemispheres that were hemodynamically compromised despite normal baseline OEF.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. E. M. Nemoto, H. Yonas, H. Kuwabara, R. Pindzola, D. Sashin, C. C. Meltzer, J. C. Price, and Y. F. Change, Detection of stage II compromised cerebrovascular reserve by Xenon-CT cerebral blood flow with acetazolamide and oxygen extraction fraction by positron emission tomography, in: Brain Imaging Using PET, edited by M. Senda, Y. Kimura, and P. Herscovitch (Academic Press, New York, 2002), pp. 259–267.

    Google Scholar 

  2. R. P. Woods, S. R. Cherry, and J. C. Mazziotta, Rapid automated algorithm for aligning and reslicing PET images, J. Comp. Assist. Tomog. 16, 620–633 (1992).

    Article  CAS  Google Scholar 

  3. S. Ohta, E. Meyer, H. Fujita, D. C. Reutens, A. Evans, and A. Gjedde, Cerebral [15O] water clearance in humans determined by PET: I. Theory and normal values, J. Cereb. Blood Flow Metab. 16, 765–780 (1966).

    Google Scholar 

  4. H. Iida, I. Kanno, S. Miura, M. Murakami, K. Takahashi, and K. Uemura, Error analysis of a quantitative cerebral blood flow measurement using H2 15O autoradiography and positron emission tomography with respect to the dispersion of the input function, J. Cereb. Blood Flow Metab. 6, 536–545 (1986).

    PubMed  CAS  Google Scholar 

  5. M. A. Mintun, M. E. Raichle, W. R. Martin, and P. Herscovitch, Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography, J. Nucl. Med. 25, 177–187 (1983).

    Google Scholar 

  6. S. Ohta, E. Meyer, and C. J. Thompson, Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen, J. Cereb. Blood Flow Metab. 12, 179–192 (1992).

    PubMed  CAS  Google Scholar 

  7. E. M. Nemoto, H. Yonas, H. Kuwabara, R. R. Pindzola, D. Sashin, C. C. Meltzer, J. C. Price, Y. Chang, and D. W. Johnson, Identification of hemodynamic compromise by CVR and OEF in occlusive vascular disease, J. Cereb. Blood Flow Metab. (In press, October 2004).

    Google Scholar 

  8. I. Kanno, K. Uemura, S. Higano, M. Murakami, H. Iida, S. Miura, F. Shishido, A. Inugami, and I. Sayama, Oxygen extraction fraction at maximally vasodilated tissue in the ischemic brain estimated from the regional CO2 responsiveness measured by positron emission tomography, J. Cereb. Blood Flow Metab. 8(2), 227–235 (1988).

    PubMed  CAS  Google Scholar 

  9. T. Nariai, R. Suzuki, K. Hirakawa, T. Maehara, K. Ishii, and M. Senda, Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography, Am. J. Neuroradiol. 16(3), 563–570 (1995).

    PubMed  CAS  Google Scholar 

  10. M. Imaizumi, K. Kitagawa, K. Hashikawa, N. Oku, T. Teratani, M. Takasawa, T. Yoshikawa, P. Rishu, T. Ohtsuki, M. Hori, M. Matsumoto, and T. Nishimura, Detection of misery perfusion with split-dose 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases, Stroke 33(9), 2217–2223 (2002).

    Article  PubMed  CAS  Google Scholar 

  11. H. Yamauchi, H. Fukuyama, Y. Nagahama, H. Nabatame, M. Ueno, S. Nishizawa, J. Konishi, and H. Shio, Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases, J. Nucl. Med. 40, 1992–1998 (1999).

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Nemoto, E.M. et al. (2005). Differentiating Hemodynamic Compromise by the OEF Response to Acetazolamide in Occlusive Vascular Disease. In: Okunieff, P., Williams, J., Chen, Y. (eds) Oxygen Transport to Tissue XXVI. Advances in Experimental Medicine and Biology, vol 566. Springer, Boston, MA. https://doi.org/10.1007/0-387-26206-7_19

Download citation

Publish with us

Policies and ethics